Angiotensin II receptor blocker (ARB)
Telmisartan
Brand names: Micardis
Adult dose
Dose: Initial 40mg PO OD; usual 20–80mg OD
Route: PO
Frequency: OD
Dose adjustments
Renal
Use cautiously
Clinical pearls
- Hypertension, CV risk reduction (ONTARGET)
- Long half-life (~24h)
Contraindications
- Pregnancy
- Bilateral renal artery stenosis
- Severe hepatic impairment
- Cholestasis
Side effects
- Dizziness
- Hyperkalaemia
- Hypotension
- Renal impairment
- Angioedema (rare)
Interactions
- NSAIDs
- K-sparing diuretics
- Lithium
- ACEi (avoid combination)
Monitoring
- U&E
- BP
Reference: BNF; NICE NG136; ESC; https://bnf.nice.org.uk/drugs/telmisartan/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines